Apollomics(us:APLM)

    9.75

    +4.06%

    Updated on 2024-12-22

    Open:8.65
    Close:9.75
    High:10.50
    Low:7.62
    Pre Close:9.37
    Volume:194297.00
    Amount:1.82M
    Turnover:17.62%
    Shares:1.10M
    MarketCap:10.75M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-03-3117962126910.75%416
    2023-12-311788501639.89%625
    2023-09-30121846739320.64%413
    2023-06-301214075301.57%404
    2023-03-314613691641.58%5139
    2022-12-31421014721675.57%568
    2022-09-3037982124473.14%345
    2022-06-3037936522469.75%583
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Orbimed Advisors Llc85654569.57%0
    2024-03-31Exchange Traded Concepts, Llc3876090.43%351936986.56%
    2024-03-31Boothbay Fund Management, Llc3737150.42%373715
    2024-03-31Powell Investment Advisors, Llc1302970.15%130297
    2024-03-31Geode Capital Management, Llc572240.06%0
    2024-03-31Bensler, Llc250880.03%0
    2024-03-31George Kaiser Family Foundation249840.03%0
    2024-03-31Commonwealth Equity Services, Llc200000.02%0
    2024-03-31Jane Street Group, Llc190720.02%19072
    2024-03-31Warberg Asset Management Llc100260.01%10026

    About

    Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
    Address:989 East Hillsdale Boulevard,Suite 220

    Market Movers